vx-745 has been researched along with imidazole in 1 studies
| Studies (vx-745) | Trials (vx-745) | Recent Studies (post-2010) (vx-745) | Studies (imidazole) | Trials (imidazole) | Recent Studies (post-2010) (imidazole) |
|---|---|---|---|---|---|
| 58 | 1 | 35 | 2,440 | 6 | 1,117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doherty, JB; Natarajan, SR | 1 |
1 review(s) available for vx-745 and imidazole
| Article | Year |
|---|---|
P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.
Topics: Binding Sites; Drug Design; Enzyme Inhibitors; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridazines; Pyrimidines; Pyrimidinones; Structure-Activity Relationship | 2005 |